[PDF][PDF] High frequency of recombination-driven allelic diversity and temporal variation of Plasmodium falciparum msp1 in Tanzania
K Tanabe, N Sakihama, I Rooth, A Bjorkman… - American Journal of …, 2007 - academia.edu
A major mechanism for the generation allelic diversity in the Plasmodium falciparum msp1
gene is meiotic recombination in the Anopheles mosquito. The frequency of recombination …
gene is meiotic recombination in the Anopheles mosquito. The frequency of recombination …
Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for …
D Yuen, WH Leung, R Cheung, C Hashimoto, SF Ng… - Vaccine, 2007 - Elsevier
The Plasmodium falciparum merozoite surface protein 1 (MSP1), MSP1-42 and MSP1-19
are protective malaria vaccines. MSP1-42 is cleaved to form MSP1-33 and MSP1-19. The …
are protective malaria vaccines. MSP1-42 is cleaved to form MSP1-33 and MSP1-19. The …
Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1
DC Kaushal, NA Kaushal, A Narula, N Kumar, SK Puri… - 2007 - nopr.niscpr.res.in
Plasmodium vivax is one of the most widely distributed human malaria parasites and due to
drug-resistant strains, its incidence and prevalence has increased, thus an effective vaccine …
drug-resistant strains, its incidence and prevalence has increased, thus an effective vaccine …
Baculovirus produced Plasmodium falciparum vaccine
S Chang, K Kramer, W Gosnell, T Nishimura - US Patent 7,285,274, 2007 - Google Patents
US7285274B2 - Baculovirus produced Plasmodium falciparum vaccine - Google Patents
US7285274B2 - Baculovirus produced Plasmodium falciparum vaccine - Google Patents …
US7285274B2 - Baculovirus produced Plasmodium falciparum vaccine - Google Patents …
Malaria MSP-1 C-terminal enhanced subunit vaccine
DE Clements, T Humphreys - 2007 - Google Patents
A vaccine or immunogenic composition is described that contains recombinantly produced,
secreted, forms of malaria MSP-I C-terminal subunit proteins from any of the Plasmodium …
secreted, forms of malaria MSP-I C-terminal subunit proteins from any of the Plasmodium …
Diversidade Genética e reconhecimento imune de proteínas de superfície de merozoítos de plasmodium falciparum (MSP-1 e MSP-2) em indivíduos expostos à …
KKG Scopel - 2007 - repositorio.ufmg.br
ResumoUma das características da maioria dos antígenos de estágios extracelulares dos
plasmódios é a presença de regiões repetitivas contendo epitopos imunodominantes. As …
plasmódios é a presença de regiões repetitivas contendo epitopos imunodominantes. As …
Utilization of Nucleotide Probes in PCR‐ELISA Procedure for the Quantitative Determination of Plasmodium Falciparum DNA in Malaria
K Vu Nguyen - Analytical letters, 2007 - Taylor & Francis
The research work reported herein is the development of a simple and specific quantitative
procedure for the determination of P. falciparum DNA in malaria that involves the direct …
procedure for the determination of P. falciparum DNA in malaria that involves the direct …
Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti …
M Nagata, T Wong, D Clements, G Hui - Experimental parasitology, 2007 - Elsevier
Hyperimmunization with Plasmodium falciparum MSP1-42 could induce antibodies that
have little or no parasite growth inhibitory activities. These antisera had no blocking activities …
have little or no parasite growth inhibitory activities. These antisera had no blocking activities …
Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
S Longacre-Andre, C Roth, F Nato… - US Patent App. 11 …, 2007 - Google Patents
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C ([C@@ H](C
(= O) N [C@ H](C (= O) N [C@@ H](CS) C (= O) N [C@@ H](CC (N)= O) C (= O) N [C …
(= O) N [C@ H](C (= O) N [C@@ H](CS) C (= O) N [C@@ H](CC (N)= O) C (= O) N [C …